(Q48553143)

12 February 2018

title

MCPP but not TFMPP is an antagonist at cardiac 5HT3 receptors (English)

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

12 November 2022

author name string

D. W. Robertson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736030

12 November 2022

W. Bloomquist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736030

12 November 2022

D. T. Wong

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736030

12 November 2022

M. L. Cohen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1736030

12 November 2022

language of work or name

English

0 references

publication date

1 January 1992

1 reference

12 February 2018

full work available at URL

https://api.elsevier.com/content/article/PII:002432059290372V?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

https://api.elsevier.com/content/article/PII:002432059290372V?httpAccept=text/plain

12 November 2022

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

12 November 2022

1 reference

12 February 2018

volume

50

1 reference

12 February 2018

page(s)

599-605

1 reference

12 February 2018

issue

8

1 reference

12 February 2018

5-HT1 and 5-HT2 binding characteristics of some quipazine analogues

cites work

1

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Antagonism of vascular serotonin receptors by m-chlorophenylpiperazine and m-trifluoromethylphenylpiperazine

12 November 2022

4

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Further studies on the blockade of 5-HT depolarizations of rabbit vagal afferent and sympathetic ganglion cells by MDL 72222 and other antagonists

12 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Specific [3H]LY278584 binding to 5-HT3 recognition sites in rat cerebral cortex

12 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

The cardiovascular effects of quipazine are mediated by peripheral 5-HT2 and 5-HT3 receptors in anaesthetized rats.

12 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

[3H]quipazine labels 5-HT3 recognition sites in rat cortical membranes.

12 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Binding of arylpiperazines to 5-HT3 serotonin receptors: results of a structure-affinity study

12 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Further evidence that the serotonin receptor in the rat stomach fundus is not 5HT1A or 5HT1B.

12 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Identification of serotonin M-receptor subtypes and their specific blockade by a new class of drugs.

12 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

'[3H]quipazine' degradation products label 5-HT uptake sites.

12 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.

12 November 2022

15

1 reference

https://api.crossref.org/works/10.1016/0024-3205(92)90372-V

12 November 2022

Identifiers

1 reference

12 February 2018

1 reference

12 February 2018